Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Abacavir for salvage or intensification.

GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies - 1 Jan 1999

Torres G

Abstract excerpt

Abacavir (Ziagen), a newly approved nucleoside analog, could be one of the most potent antiretrovirals available. Most of the clinical trials on abacavir have focused on patients who have never been treated for HIV, and they have responded well to the drug. The drug is not expected to be as effective in patients who have exhausted treatment options, as was demonstrated by Glaxo study CNA2007. The most common side...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Clinical Trials as Topic
Share to Dideoxynucleosides

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Drug Therapy, Combination

Share to Salvage Therapy

Share to Viral Load

Share to Virus Replication

Source

Identifiers

PMID: 11366111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Abacavir for salvage or intensification.PMID 11366111Read ↗

A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.Semantic proximity Read ↗

New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.Semantic proximity Read ↗

Intensification of treatment with pegylated interferon alfa in patients coinfected with HIV and HBV genotype H or G being treated with a tenofovir/emtricitabine-containing regimen.Semantic proximity Read ↗

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.Semantic proximity Read ↗

Treatment Intensification with Raltegravir in Subjects with Sustained HIV-1 Viraemia Suppression: A Randomized 48-Week StudySemantic proximity Read ↗

Abacavir (Ziagen(®)) use between 2003 and 2008 in France according to the electronic medical record NADIS(®).Semantic proximity Read ↗

The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study Team.Semantic proximity Read ↗

Efficacy of boosted protease inhibitor monotherapy in patients with complex medical problems.Semantic proximity Read ↗

Switch to abacavir-based triple nucleoside regimens in HIV-1 infected patients never treated with suboptimal antiretroviral therapy: a review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.